Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  4basebio UK Societas    4BB   GB00BLD8ZL39

4BASEBIO UK SOCIETAS

(4BB)
  Report
Delayed Quote. Delayed London Stock Exchange - 04/12 11:35:23 am
335 GBX   --.--%
02/264BASEBIO UK SOCIETAS  : Director/PDMR Shareholding
PR
02/224BAO UK  : 4basebio UK Societas - Holding(s) in Company
PR
02/194BAO  : 4basebio UK Societas - Holding(s) in Company
PR
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed London Stock Exchange
04/06/2021 04/07/2021 04/08/2021 04/09/2021 04/12/2021 Date
335(c) 315(c) 320(c) 335(c) 335(c) Last
0 8 574 10 221 5 316 4 961 Volume
0.00% -5.97% +1.59% +4.69% 0.00% Change
More quotes
Financials
Sales 2020 0,40 M 0,55 M 0,55 M
Net income 2020 -0,91 M -1,25 M -1,25 M
Net cash position 2020 12,6 M 17,3 M 17,3 M
P/E ratio 2020 -28,4x
Yield 2020 -
Sales 2021 0,20 M 0,27 M 0,27 M
Net income 2021 -3,27 M -4,49 M -4,49 M
Net cash position 2021 8,69 M 11,9 M 11,9 M
P/E ratio 2021 -12,6x
Yield 2021 -
Capitalization 41,3 M 56,7 M 56,7 M
EV / Sales 2020 71,7x
EV / Sales 2021 163x
Nbr of Employees -
Free-Float -
More Financials
Company
4basebio UK Societas is a United Kingdom-based specialist life sciences company. The Company is engaged in developing next generation gene therapy technologies and solutions. The Company is focused on supplying therapeutic deoxyribonucleic (DNA) for gene therapies and DNA vaccines and also for providing solutions for delivery of the DNA based products to patients. The Company focuses to manufacture and supply... 
More about the company
All news about 4BASEBIO UK SOCIETAS
02/264BASEBIO UK SOCIETAS  : Director/PDMR Shareholding
PR
02/224BAO UK  : 4basebio UK Societas - Holding(s) in Company
PR
02/194BAO  : 4basebio UK Societas - Holding(s) in Company
PR
02/174BAO UK  : 4basebio UK Societas Admitted To Trading On London's AIM Market
MT
More news
News in other languages on 4BASEBIO UK SOCIETAS

- No features available -

More news
Chart 4BASEBIO UK SOCIETAS
Duration : Period :
4basebio UK Societas Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 1
Average target price
Last Close Price 3,35 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers and Directors
NameTitle
Heikki Lanckriet CEO, Executive Director & Chief Scientific Officer
Timothy Paul McCarthy Independent Non-Executive Chairman
Maria del Pilar de la Huerta Martinez Independent Non-Executive Director
Joseph Manuel Fernández Non-Executive Director
Hansjörg Plaggemars Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
4BASEBIO UK SOCIETAS0.00%57
MODERNA, INC.34.89%56 442
LONZA GROUP AG-3.59%43 993
IQVIA HOLDINGS INC.15.90%39 822
CELLTRION, INC.-13.51%37 705
SEAGEN INC.-18.44%25 900